Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.4931 USD | +1.72% | -1.38% | -24.14% |
Mar. 25 | Wall Street Set to Open Modestly Lower Monday Ahead of Housing, Inflation Data | MT |
Mar. 25 | Top Premarket Gainers | MT |
Business Summary
Number of employees: 2
Managers
Managers | Title | Age | Since |
---|---|---|---|
David Arthur
CEO | Chief Executive Officer | 61 | 19-07-18 |
Mark Rosenblum
DFI | Director of Finance/CFO | 70 | 19-09-09 |
Bruce McCreedy
BRD | Director/Board Member | 64 | 19-07-18 |
Nadeem Q. Mirza
PRN | Corporate Officer/Principal | - | 20-07-22 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Arnold Hanish
BRD | Director/Board Member | 76 | 19-07-18 |
Paul Lammers
BRD | Director/Board Member | 66 | 19-07-18 |
Jonathan Lieber
BRD | Director/Board Member | 54 | 20-06-18 |
William McVicar
CHM | Chairman | 66 | 19-07-18 |
Bruce McCreedy
BRD | Director/Board Member | 64 | 19-07-18 |
Tess Burleson
BRD | Director/Board Member | 57 | 19-07-18 |
David Arthur
CEO | Chief Executive Officer | 61 | 19-07-18 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 4,314,433 | 4,023,865 ( 93.27 %) | 0 | 93.27 % |
Company contact information
Salarius Pharmaceuticals, Inc.
2450 Holcombe Boulevard Suite X
77021, Houston
+
http://salariuspharma.comSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-24.14% | 2.09M | |
-1.42% | 41.35B | |
+42.15% | 40.38B | |
+1.97% | 39.05B | |
-14.19% | 26.67B | |
+1.82% | 24.07B | |
-24.55% | 18.36B | |
-4.07% | 11.68B | |
+21.36% | 11.6B | |
+8.20% | 11.15B |
- Stock Market
- Equities
- SLRX Stock
- Company Salarius Pharmaceuticals, Inc.